Cargando…
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines
BACKGROUND AND OBJECTIVE: Pharmaceutical policies are generally based on the assumption that involved stakeholders make rational decisions. However, behavioral economics has taught us that this is not always the case as people deviate from rational behavior in rather predictable patterns. This scopi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379236/ https://www.ncbi.nlm.nih.gov/pubmed/35972683 http://dx.doi.org/10.1007/s40258-022-00751-y |
_version_ | 1784768634567000064 |
---|---|
author | Vandenplas, Yannick Simoens, Steven Turk, Florian Vulto, Arnold G. Huys, Isabelle |
author_facet | Vandenplas, Yannick Simoens, Steven Turk, Florian Vulto, Arnold G. Huys, Isabelle |
author_sort | Vandenplas, Yannick |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Pharmaceutical policies are generally based on the assumption that involved stakeholders make rational decisions. However, behavioral economics has taught us that this is not always the case as people deviate from rational behavior in rather predictable patterns. This scoping review examined to what extent behavioral concepts have already been applied in the pharmaceutical domain and what evidence exists about their effectiveness, with the aim of formulating future applications and research hypotheses on policymaking for best-value biologicals. METHODS: A scoping literature review was conducted on the evidence of behavioral applications to pharmaceuticals. Scientific databases (Embase, MEDLINE, APA PsycArticles, and Scopus) were searched up to 20 October, 2021. RESULTS: Forty-four full-text scientific articles were identified and narratively described in this article. Pharmaceutical domains where behavioral concepts have been investigated relate to influencing prescribing behavior, improving medication adherence, and increasing vaccination uptake. Multiple behavioral concepts were examined in the identified studies, such as social norms, defaults, framing, loss aversion, availability, and present bias. The effectiveness of the applied interventions was generally positive, but depended on the context. Some of the examined interventions can easily be translated into effective policy interventions for best-value biological medicines. However, some applications require further investigation in a research context. CONCLUSIONS: Applications of behavioral economics to pharmaceutical policymaking are promising. However, further research is required to investigate the effect of behavioral applications on policy interventions for a more sustainable market environment for best-value biological medicines. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-022-00751-y. |
format | Online Article Text |
id | pubmed-9379236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-93792362022-08-16 Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines Vandenplas, Yannick Simoens, Steven Turk, Florian Vulto, Arnold G. Huys, Isabelle Appl Health Econ Health Policy Systematic Review BACKGROUND AND OBJECTIVE: Pharmaceutical policies are generally based on the assumption that involved stakeholders make rational decisions. However, behavioral economics has taught us that this is not always the case as people deviate from rational behavior in rather predictable patterns. This scoping review examined to what extent behavioral concepts have already been applied in the pharmaceutical domain and what evidence exists about their effectiveness, with the aim of formulating future applications and research hypotheses on policymaking for best-value biologicals. METHODS: A scoping literature review was conducted on the evidence of behavioral applications to pharmaceuticals. Scientific databases (Embase, MEDLINE, APA PsycArticles, and Scopus) were searched up to 20 October, 2021. RESULTS: Forty-four full-text scientific articles were identified and narratively described in this article. Pharmaceutical domains where behavioral concepts have been investigated relate to influencing prescribing behavior, improving medication adherence, and increasing vaccination uptake. Multiple behavioral concepts were examined in the identified studies, such as social norms, defaults, framing, loss aversion, availability, and present bias. The effectiveness of the applied interventions was generally positive, but depended on the context. Some of the examined interventions can easily be translated into effective policy interventions for best-value biological medicines. However, some applications require further investigation in a research context. CONCLUSIONS: Applications of behavioral economics to pharmaceutical policymaking are promising. However, further research is required to investigate the effect of behavioral applications on policy interventions for a more sustainable market environment for best-value biological medicines. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-022-00751-y. Springer International Publishing 2022-08-16 2022 /pmc/articles/PMC9379236/ /pubmed/35972683 http://dx.doi.org/10.1007/s40258-022-00751-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Systematic Review Vandenplas, Yannick Simoens, Steven Turk, Florian Vulto, Arnold G. Huys, Isabelle Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines |
title | Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines |
title_full | Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines |
title_fullStr | Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines |
title_full_unstemmed | Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines |
title_short | Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines |
title_sort | applications of behavioral economics to pharmaceutical policymaking: a scoping review with implications for best-value biological medicines |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379236/ https://www.ncbi.nlm.nih.gov/pubmed/35972683 http://dx.doi.org/10.1007/s40258-022-00751-y |
work_keys_str_mv | AT vandenplasyannick applicationsofbehavioraleconomicstopharmaceuticalpolicymakingascopingreviewwithimplicationsforbestvaluebiologicalmedicines AT simoenssteven applicationsofbehavioraleconomicstopharmaceuticalpolicymakingascopingreviewwithimplicationsforbestvaluebiologicalmedicines AT turkflorian applicationsofbehavioraleconomicstopharmaceuticalpolicymakingascopingreviewwithimplicationsforbestvaluebiologicalmedicines AT vultoarnoldg applicationsofbehavioraleconomicstopharmaceuticalpolicymakingascopingreviewwithimplicationsforbestvaluebiologicalmedicines AT huysisabelle applicationsofbehavioraleconomicstopharmaceuticalpolicymakingascopingreviewwithimplicationsforbestvaluebiologicalmedicines |